Related Experiment Video
Updated: Jan 7, 2026

04:33
Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
1.2K
Association of Anaemia and Depression: A Systematic Review and Meta-analysis
Bhupesh Gupta1, Ramita Goel2, Vimal Satodiya3
1Maharishi Markandeshwar Institute of Medical Sciences and Research, Mullana, India.
Nigerian Medical Journal : Journal of the Nigeria Medical Association
|December 31, 2025
Summary
Depression affects 36% of anemia patients, with higher rates in sickle cell anemia and certain continents. Early screening is crucial, especially for young patients and in resource-limited areas.
Area of Science:
- Epidemiology
- Psychiatry
- Hematology
Background:
- Anemia is a global health issue affecting diverse populations.
- Depression is a significant comorbidity with potential impacts on anemia management.
- Understanding the prevalence of depression in anemia patients is crucial for comprehensive care.
Purpose of the Study:
- To determine the overall prevalence of depression in patients with all types of anemia.
- To investigate variations in depression prevalence across different anemia types, age groups, genders, and geographical regions.
- To provide evidence for targeted screening and intervention strategies.
Main Methods:
- A comprehensive meta-analysis of observational epidemiological studies was conducted.
- Literature search included PubMed, Scopus, Embase, and Google Scholar (2003-2024).
- Random-effects model used for meta-analysis; JBI score for quality appraisal; heterogeneity assessed with Q and I2 statistics; publication bias evaluated using funnel plots and Egger's test.
Main Results:
- The pooled prevalence of depression among anemia patients was estimated at 36% (95% CI: 28-45%).
- Higher prevalence observed in sickle cell anemia (42%), Thalassemia (35%), and Iron deficiency anemia (20%).
- Depression rates were notably higher in Asia (40%) and Africa (37%) compared to America (28%) and Europe (20%), with younger patients showing increased prevalence.
Conclusions:
- A significant proportion of anemia patients experience depression, necessitating clinical attention.
- Routine depression screening during anemia follow-ups is recommended, particularly for high-risk groups and in resource-limited settings.
- Further research into the underlying mechanisms and effective interventions for depression in anemia is warranted.
Related Concept Videos
Depression: Overview
741
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
741
Depressive Disorders: Etiology
408
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
408
Depressive Disorders: MDD and Dysthymia
564
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
564
Long-term Depression
33.0K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.0K
Long-term Depression
3.0K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
3.0K
Antidepressant Drugs: MAOIs and Other Agents
765
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
765

